1171245-83-2

Upstream product

• 1171245-82-1 N-{4-hydroxy-3-[hydroxy(diphenyl)methyl]phenyl}acetamide 
• 89922-82-7 3-(tert-butyldimethylsilanyloxy)propionaldehyde 
• 42753-75-3 methyl 5-amino-2-hydroxybenzoate 
• 89-57-6 5-Aminosalicylic Acid 

Downstream Products

• 1171245-80-9 N-ethyl-2-[2-(TBS)oxyethyl]-4,4-diphenyl-4H-1,3-benzodioxin-6-amine 
• 1463522-90-8 C₃₁H₃₂BrNO₄ 
• 1463523-04-7 2-(6-(ethyl(prop-2-yn-1-yl)amino)-4,4-diphenyl-4H-benzo[d][1,3]dioxin-2-yl)ethanol 

Relevant academic research and scientific papers

Application of new photolabile protecting groups as photocleavable joints of block copolymers

New photoresponsive block copolymers (BCPs) have been developed by incorporating photocleavable units. These photocleavable units are derived from robust photolabile protecting groups (PPGs); UV irradiation cleaves the BCPs and releases a well-defined chemically active functional group at the cleaved end of a PS polymer. The Royal Society of Chemistry 2013.

PHOTO-ACTIVATABLE THERAPEUTIC AGENTS AND METHODS OF USING

Novel photo-activatable pro-therapeutic agents and methods for their synthesis and use are described. The photo-activatable pro-therapeutic agents are inactive pro-forms of compounds that can be activated in situ, for example, by providing a pro-therapeutic agent to a subject and photo-activating the pro-therapeutic agent at a selected area of the subject. Also disclosed are methods for administering the photo-activatable pro-therapeutic agents to a subject then activating the pro-therapeutic agents at a selected area of the subject by exposing that area to light.

Photolabile carbonyl protecting group: A new tool for light-controlled release of anticancer agents

A new type of photolabile carbonyl-protecting group was utilized in releasing anticancer agents upon irradiation at 350 nm in an aqueous environment.